Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases
- PMID: 8642463
- DOI: 10.1093/jn/126.suppl_4.1238S
Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases
Abstract
Results of basal plasma homocyst(e)ine concentrations in patients reported in the literature are reviewed, with emphasis on the series of subjects analyzed by the author. Findings support the hypothesis that plasma homocyst(e)ine is a risk factor for coronary, cerebral and peripheral arterial occlusive diseases, as well as for carotid thickening. Results of four studies show that heritability influences plasma homocyst(e)ine. Moreover, data suggest that a graded risk for atherothrombotic disease is distributed across the entire distribution of plasma homocyst(e)ine levels. Elevated levels of homocyst(e)ine can be decreased effectively by supplementary folate, occasionally requiring the addition of vitamin B-12, vitamin B-6, choline or betaine. Consequently, it is important that placebo-controlled clinical trials be conducted to determine whether the clinical evolution of arterial occlusive diseases is influenced by those supplements.
Similar articles
-
Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review.Clin Chem. 1995 Jan;41(1):173-6. Clin Chem. 1995. PMID: 7813076 Review.
-
Homocyst(e)ine and arterial occlusive diseases.J Intern Med. 1994 Dec;236(6):603-17. doi: 10.1111/j.1365-2796.1994.tb00854.x. J Intern Med. 1994. PMID: 7989896 Review.
-
Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease.Atherosclerosis. 1996 Sep 27;126(1):27-34. doi: 10.1016/0021-9150(96)05890-x. Atherosclerosis. 1996. PMID: 8879431
-
[Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].Z Kardiol. 2001 Jan;90(1):1-11. doi: 10.1007/s003920170206. Z Kardiol. 2001. PMID: 11220081 Review. German.
-
Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.Stroke. 1990 Apr;21(4):572-6. doi: 10.1161/01.str.21.4.572. Stroke. 1990. PMID: 2326839
Cited by
-
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.Cochrane Database Syst Rev. 2013 Jul 19;2013(7):CD003285. doi: 10.1002/14651858.CD003285.pub2. Cochrane Database Syst Rev. 2013. PMID: 23881650 Free PMC article. Review.
-
Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.Neurochem Int. 2008 Dec;53(6-8):214-9. doi: 10.1016/j.neuint.2008.07.008. Epub 2008 Aug 3. Neurochem Int. 2008. PMID: 18725259 Free PMC article.
-
Folate and vitamin B12 status of a multiethnic adult population.J Natl Med Assoc. 2006 Jan;98(1):67-72. J Natl Med Assoc. 2006. PMID: 16532981 Free PMC article.
-
Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis.Arthritis Res Ther. 2005;7(6):R1404-11. doi: 10.1186/ar1839. Epub 2005 Oct 14. Arthritis Res Ther. 2005. PMID: 16277693 Free PMC article. Clinical Trial.
-
Plasma homocysteine and retinal artery occlusive disease: a case-control study.Ann Saudi Med. 2004 May-Jun;24(3):186-8. doi: 10.5144/0256-4947.2004.186. Ann Saudi Med. 2004. PMID: 15307456 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources